yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q34536718-22C2C423-CDC4-4FF9-8DD1-A109D8063285
Q34536718-22C2C423-CDC4-4FF9-8DD1-A109D8063285
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34536718-22C2C423-CDC4-4FF9-8DD1-A109D8063285
Gastroduodenal tolerability of lumiracoxib vs placebo and naproxen: a pilot endoscopic study in healthy male subjects.
P2860
Q34536718-22C2C423-CDC4-4FF9-8DD1-A109D8063285
BestRank
Statement
http://www.wikidata.org/entity/statement/Q34536718-22C2C423-CDC4-4FF9-8DD1-A109D8063285
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
658e6355971b6e3e8d65d5183a5f85e335903567
P2860
Do cyclooxygenase-2 inhibitors provide benefits similar to those of traditional nonsteroidal anti-inflammatory drugs, with less gastrointestinal toxicity?